Trademark: 90696292
Status Date
Monday, December 4, 2023
Filing Date
Friday, May 7, 2021
Published for Opposition
Tuesday, March 8, 2022
Abandoned Date
Monday, December 4, 2023
5 Eye drops; eye drops for the treatment of ophthalmic disorders
42 Research and development of ophthalmic pharmaceuticals
Dec 4, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 4, 2023
Abandonment - No Use Statement Filed
Oct 16, 2023
Teas Change Of Correspondence Received
Oct 16, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 16, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 29, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 27, 2023
Sou Extension 2 Granted
Apr 27, 2023
Sou Extension 2 Filed
Apr 27, 2023
Sou Teas Extension Received
Nov 2, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 31, 2022
Sou Extension 1 Granted
Oct 31, 2022
Sou Extension 1 Filed
Oct 31, 2022
Sou Teas Extension Received
Jun 23, 2022
Automatic Update Of Assignment Of Ownership
May 3, 2022
Noa E-Mailed - Sou Required From Applicant
Mar 8, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 8, 2022
Published For Opposition
Feb 16, 2022
Notification Of Notice Of Publication E-Mailed
Feb 3, 2022
Approved For Pub - Principal Register
Jan 31, 2022
Teas/Email Correspondence Entered
Jan 30, 2022
Correspondence Received In Law Office
Jan 30, 2022
Teas Response To Office Action Received
Jan 13, 2022
Notification Of Non-Final Action E-Mailed
Jan 13, 2022
Non-Final Action E-Mailed
Jan 13, 2022
Non-Final Action Written
Jan 12, 2022
Assigned To Examiner
Aug 9, 2021
New Application Office Supplied Data Entered
May 11, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
